companies that manufacture glp-1 medications Did you know? India is now the world's 2nd largest GLP‑1 market. With 2026 patent expiries ahead, a massive opportunity could open up in diabetes & obesity care #MarketTalks #EdelweissMutualFund The Biggest Winner of GLP-1

So if youre still on a lower or mid-range dose, increasing it under medical supervision can often give you the boost you need to restart progress

Klipp, A., Burger, M

According to the FDA approval announcement, Zepbound (tirzepatide) represents a breakthrough in obesity treatment as the first and only FDA-approved weight loss medication that targets two distinct hormone receptors simultaneously

Conversely, higher levels of IGF-1 correlate with better insulin sensitivity and lower blood glucose levels

Without enough caloriesespecially carbohydrates and proteinyour body may not have the energy it needs to support: Endurance Strength Recovery Lean muscle maintenance Some patients on GLP-1 meds report early fatigue , low energy during workouts , or longer recovery times often tied to undernutrition rather than the drug itself